Effects of combined treatment of insulin and human parathyroid hormone(1–34) on cancellous bone mass and structure in streptozotocin-induced diabetic rats
- 14 June 2003
- journal article
- research article
- Published by Elsevier BV in Bone
- Vol. 33 (1), 108-114
- https://doi.org/10.1016/s8756-3282(03)00169-8
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1-34) on Bone Histomorphometry and Serum Chemistry in RatsEndocrinology, 1997
- The Mitogenic Effect of Parathyroid Hormone Is Associated with E2F-Dependent Activation of Cyclin-Dependent Kinase 1 (cdc2) in Osteoblast PrecursorsJournal of Bone and Mineral Research, 1997
- Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acidsEndocrinology, 1994
- Biologically meaningful determinants of the in vitro strength of lumbar vertebraeBone, 1991
- A new manual method for assessing two-dimensional cancellous bone structure: Comparison between iliac crest and lumbar vertebraJournal of Bone and Mineral Research, 1991
- The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell lineJournal of Bone and Mineral Research, 1989
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin DJournal of Bone and Mineral Research, 1986
- IS DIABETIC OSTEOPOROSIS DUE TO MICROANGIOPATHY?The Lancet, 1980
- Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.BMJ, 1980